Breaking news: high-speed race ends in arrest - how oncogenes induce senescence

被引:59
作者
Di Micco, Raffaella [1 ]
Fumagalli, Marzia [1 ]
di Fagagna, Fabrizio d'Adda [1 ]
机构
[1] FIRC Inst Mol Oncol Fdn, IOFM Fdn, I-20139 Milan, Italy
关键词
D O I
10.1016/j.tcb.2007.07.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Oncogene activation in normal cells induces a permanent proliferative arrest known as cellular senescence. This phenomenon restrains the expansion of cells that bear an activated oncogene and acts as a powerful tumor-suppressive process. Although the full molecular mechanisms are still being elucidated, it has been observed recently that some oncogenes alter the DNA-replication process and cause DNA-damage accumulation. DNA-damage checkpoint-response activation together with the increased appearance of heterochromatin formation that leads to transcriptional silencing of proliferative genes are, presently, the two main mechanisms known that establish and maintain oncogene-induced senescence. Here, we discuss the most recent advancements in understanding the molecular and cellular mechanisms that control cellular senescence caused by oncogene activation and their impact on cancer studies.
引用
收藏
页码:529 / 536
页数:8
相关论文
共 84 条
[1]   Ras induces chromosome instability and abrogation of the DNA damage response [J].
Abulaiti, Adili ;
Fikaris, Aphrothiti J. ;
Tsygankova, Oxana M. ;
Meinkoth, Judy L. .
CANCER RESEARCH, 2006, 66 (21) :10505-10512
[2]   Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging [J].
Adams, Peter D. .
GENE, 2007, 397 (1-2) :84-93
[3]   Replication in context: dynamic regulation of DNA replication patterns in metazoans [J].
Aladjem, Mirit I. .
NATURE REVIEWS GENETICS, 2007, 8 (08) :588-600
[4]   Altered expression of DNA double-strand break detection and repair proteins in breast carcinomas [J].
Angèle, S ;
Treilleux, I ;
Brémond, A ;
Tanière, P ;
Hall, J .
HISTOPATHOLOGY, 2003, 43 (04) :347-353
[5]   Oncogenic potential of the DNA replication licensing protein CDT1 [J].
Arentson, E ;
Faloon, P ;
Seo, J ;
Moon, E ;
Studts, JM ;
Fremont, DH ;
Choi, KH .
ONCOGENE, 2002, 21 (08) :1150-1158
[6]  
BARRKOVA J, 2006, NATURE, V444, P633
[7]   DNA damage checkpoints: from initiation to recovery or adaptation [J].
Bartek, Jiri ;
Lukas, Jiri .
CURRENT OPINION IN CELL BIOLOGY, 2007, 19 (02) :238-245
[8]   Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer [J].
Bartkova, J ;
Guldberg, P ;
Gronbæk, K ;
Koed, K ;
Primdahl, H ;
Moller, K ;
Lukas, J ;
Orntoft, TF ;
Bartek, J .
ONCOGENE, 2004, 23 (52) :8545-8551
[9]   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[10]   Deconstructing PML-induced premature senescence [J].
Bischof, O ;
Kirsh, O ;
Pearson, M ;
Itahana, K ;
Pelicci, PG ;
Dejean, A .
EMBO JOURNAL, 2002, 21 (13) :3358-3369